Oligoclonal and monoclonal bands after single autologous stem cell transplant in patients with multiple myeloma: impact on overall survival and progression-free survival

References

• Kyle RA, Robinson RA, Katzmann JA. The clinical aspects of biclonal gammopathies. Review of 57 cases. Am J Med 1981;71: 999–1008.
   Google Scholar
• Cohen Y, Ben-Bassat I. [Biclonal gammopathies: clinical and theoretical aspects]. Harefuah 1993;124:393–395, 456.
   PubMedGoogle Scholar
• Vesole D, Vanier A, Flick J, et al. Monoclonal immunoglobulin isotype switches in multiple myeloma patients following high dose chemotherapy. Blood 1992;80(Suppl. 1): Abstract 122.
   PubMed Web of Science ®Google Scholar
• Hovenga S, de Wolf JT, Guikema JE, et al. Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses: a high incidence of oligoclonal serum Igs post transplantation. Bone Marrow Transplant 2000;25:723–728.
   PubMed Web of Science ®Google Scholar
• Hall SL, Tate J, Gill D, et al. Significance of abnormal protein bands in patients with multiple myeloma following autologous stem cell transplantation. Clin Biochem Rev 2009;30:113–118.
   PubMedGoogle Scholar
• Zent CS, Wilson CS, Tricot G, et al. Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation. Blood 1998;91: 3518–3523.
   PubMed Web of Science ®Google Scholar
• Mitus AJ, Stein R, Rappeport JM, et al. Monoclonal and oligoclonal gammopathy after bone marrow transplantation. Blood 1989;74:2764–2768.
   PubMed Web of Science ®Google Scholar
• de Larrea CF, Cibeira MT, Elena M, et al. Abnormal serum free light chain ratio in patients with multiple myeloma in complete remission has strong association with the presence of oligoclonal bands: implications for stringent complete remission definition. Blood 2009;114:4954–4956.
   PubMed Web of Science ®Google Scholar
• Fernandez de Larrea C, Tovar N, Cibeira MT, et al. Emergence of oligoclonal bands in patients with multiple myeloma in complete remission after induction chemotherapy: association with the use of novel agents. Haematologica 2011;96:171–173.
   PubMed Web of Science ®Google Scholar
• Mark T, Jayabalan D, Coleman M, et al. Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma. Br J Haematol 2008;143:654–660.
   PubMed Web of Science ®Google Scholar
• Wadhera RK, Kyle RA, Larson DR, et al. Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma. Blood 2012;118:2985–2987.
   Web of Science ®Google Scholar
• Durie BG, Harousseau JL, Miguel JS, et al. International uniform response criteria for multiple myeloma. Leukemia 2006;20:1467–1473.
   PubMed Web of Science ®Google Scholar
• Blade J, Samson D, Reece D, et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. Br J Haematol 1998;102:1115–1123.
   Google Scholar
• Avet-Loiseau H, Attal M, Campion L, et al. Long-term analysis of the IFM 99 trials for myeloma: cytogenetic abnormalities [t(4;14), del(17p), 1q gains] play a major role in defining long-term survival. J Clin Oncol 2012;30:1949–1952.
   PubMed Web of Science ®Google Scholar
• Alejandre ME, Madalena LB, Pavlovsky MA, et al. Oligoclonal bands and immunoglobulin isotype switch during monitoring of patients with multiple myeloma and autologous hematopoietic cell transplantation: a 16-year experience. Clin Chem Lab Med 2010;48: 727–731.
   PubMed Web of Science ®Google Scholar
• Tovar N, de Larrea CF, Arostegui JI, et al. Natural history and prognostic impact of oligoclonal humoral response in patients with multiple myeloma after autologous stem cell transplantation: long-term results from a single institution. Haematologica 2013;98: 1142–1146.
   PubMed Web of Science ®Google Scholar
• Byrne E, Giles C, Andrews J, et al. Lack of correlation between emergence of an abnormal protein band or of oligoclonal bands and survival in patients with multiple myeloma achieving complete remission following autologous stem cell transplantation. Haematologica 2011;96:e29.
   Web of Science ®Google Scholar
• Manson GV, Campagnaro E, Balog A, et al. Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significance. Bone Marrow Transplant 2012;47:1212–1216.
   PubMed Web of Science ®Google Scholar
• Guikema JE, Vellenga E, Veeneman JM, et al. Multiple myeloma related cells in patients undergoing autologous peripheral blood stem cell transplantation. Br J Haematol 1999;104:748–754.
   PubMed Web of Science ®Google Scholar
• Xiang Z, Cutler AJ, Brownlie RJ, et al. FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis. Nat Immunol 2007;8:419–429.
   PubMed Web of Science ®Google Scholar
• Brown R, Murray A, Pope B, et al. Either interleukin-12 or interferon-gamma can correct the dendritic cell defect induced by transforming growth factor beta in patients with myeloma. Br J Haematol 2004;125:743–748.
   PubMed Web of Science ®Google Scholar
• Brown RD, Pope B, Murray A, et al. Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10. Blood 2001;98:2992–2998.
   PubMed Web of Science ®Google Scholar
• Corthay A, Skovseth DK, Lundin KU, et al. Primary antitumor immune response mediated by CD4 + T cells. Immunity 2005;22: 371–383.
   PubMed Web of Science ®Google Scholar
• Leung-Hagesteijn C, Erdmann N, Cheung G, et al. Xbp1s-negative tumor B cells and pre-plasmablasts mediate therapeutic proteasome inhibitor resistance in multiple myeloma. Cancer Cell 2013;24: 289–304.
   PubMed Web of Science ®Google Scholar